Cargando…

Case report: Cholecystoduodenostomy for cholestatic liver disease in a premature infant with cystic fibrosis and short gut syndrome

BACKGROUND: Cholecystoduodenostomy is a surgical procedure that bypasses the extrahepatic biliary tree and connects the gallbladder directly to the duodenum. This case describes the successful use of this procedure in a novel situation. CASE PRESENTATION: A premature (34 weeks gestation) female infa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fawcett, Laura K., Widger, John, Henry, Guy M., Ooi, Chee Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410495/ https://www.ncbi.nlm.nih.gov/pubmed/30857526 http://dx.doi.org/10.1186/s12887-019-1443-5

Ejemplares similares

Antegrade cholangiogram via cholecystoduodenostomy in biliary pancreatitis
por: Mony, Shruti, et al.
Publicado: (2016)

Hepaticogastrostomy as salvage treatment in a case of clinical failure of cholecystoduodenostomy due to tumoral obstruction of the cystic duct
por: Quintana-Carbo, Sergi, et al.
Publicado: (2023)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Transpapillary nasocystic tube placement to allow gallbladder distention for EUS-guided cholecystoduodenostomy
por: James, Theodore W., et al.
Publicado: (2019)

Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function
por: Guo, Cheng, et al.
Publicado: (2018)

Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis
por: Wu, Bo, et al.
Publicado: (2022)

Corrigendum: Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function
por: Guo, Cheng, et al.
Publicado: (2020)

Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis
por: Coffey, Michael J., et al.
Publicado: (2019)

Secondary Malnutrition and Nutritional Intervention in Cholestatic Liver Diseases in Infants
por: Larrosa-Haro, Alfredo, et al.
Publicado: (2021)

Diet and the gut-lung axis in cystic fibrosis – direct & indirect links
por: McKay, Isabelle, et al.
Publicado: (2022)

Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
por: Li, Rina, et al.
Publicado: (2023)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
por: Shi, Qingmiao, et al.
Publicado: (2023)

Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions
por: Tam, Rachel Y., et al.
Publicado: (2022)

Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions
por: Fawcett, Laura K., et al.
Publicado: (2021)

A surprising culprit for delayed gastrointestinal bleeding after endoscopic ultrasound-guided cholecystoduodenostomy: the double-pigtail stent
por: Magahis, Patrick Tiongco, et al.
Publicado: (2022)

Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
por: Svinka, Jasmin, et al.
Publicado: (2016)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

ERRγ suppression by Sirt6 alleviates cholestatic liver injury and fibrosis
por: Hao, Lihua, et al.
Publicado: (2020)

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
por: Kimura, Masamichi, et al.
Publicado: (2022)

The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review
por: McKay, Isabelle R., et al.
Publicado: (2022)

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
por: Lee, Jung M., et al.
Publicado: (2012)

Induction of Extrahepatic Biliary Carcinoma by N‐Nitrosobis(2‐oxopropyl)amine in Hamsters Given Cholecystoduodenostomy with Dissection of the Common Duct
por: Tajima, Yoshitsugu, et al.
Publicado: (1994)

EUS-guided cholecystoduodenostomy and ERCP in a patient with surgically altered anatomy with a double-balloon endoluminal interventional platform
por: Li, Andrew A., et al.
Publicado: (2021)

Cellular crosstalk during cholestatic liver injury
por: Thomson, Joanne, et al.
Publicado: (2017)

Cystic fibrosis-related diabetes and lung disease: an update
por: Prentice, Bernadette J., et al.
Publicado: (2021)

The association of γδT lymphocytes with cystic leukomalacia in premature infants
por: Yuan, Mengjie, et al.
Publicado: (2022)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

Crushing pancreatic enzymes with enteral feeds in an extremely premature infant with cystic fibrosis—a novel and effective technique
por: Grunert, Jodi, et al.
Publicado: (2020)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)

The Role of Inflammation in Cholestatic Liver Injury
por: Chen, Jie, et al.
Publicado: (2023)

Biomarkers of inflammation in infants with cystic fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2018)

Atypical Presentation of Cystic Fibrosis in An Infant
por: Sahoo, Bandya, et al.
Publicado: (2022)

Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis
por: Nielsen, Shaun, et al.
Publicado: (2016)

The Gut-Lung Axis in Cystic Fibrosis
por: Price, Courtney E., et al.
Publicado: (2021)

High Rate of Cytomegalovirus Detection in Cholestatic Preterm Infants
por: Teng, Jonas, et al.
Publicado: (2021)

Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis
por: Li, Sha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bht0ue4h5chhc09m3c0ckaopt9